Regulation of phosphodiesterase 3 in the pulmonary arteries during the perinatal period in sheep

Pediatric Research

Volumn 66, Issue 6, 2009, Pages 682-687

  Chen, Bernadette ^a   Lakshminrusimha, Satyan ^b   Czech, Lyubov ^a   Groh, Beezly S ^a   Gugino, Sylvia F ^c   Russell, James A ^b,c   Farrow, Kathryn N ^a   Steinhorn, Robin H ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Department of Physiology and Biophysics ^*

^c UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; MILRINONE; NITRIC OXIDE; OXYGEN; PHOSPHODIESTERASE III;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREATHING; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HYDROLYSIS; LUNG ARTERY; LUNG VENTILATION; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEADY STATE; VASODILATATION;

ADMINISTRATION, INHALATION; ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; BLOTTING, WESTERN; CYCLIC AMP; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 3; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; MILRINONE; NITRIC OXIDE; OXYGEN; PULMONARY ARTERY; RESPIRATION, ARTIFICIAL; SHEEP;

EID: 73449095428     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1203/PDR.0b013e3181bce574     Document Type: Article

References (27)

1. Farrow KN, Fliman P, Steinhorn RH 2005 The diseases treated with ECMO: focus on PPHN. Semin Perinatol 29:8-14
2. Jourdan KB, Mason NA, Long L, Philips PG, Wilkins MR, Morrell NW 2001 Characterization of adenylyl cyclase isoforms in rat peripheral pulmonary arteries. Am J Physiol Lung Cell Mol Physiol 280:L1359-L1369
3. Beavo JA 1995 Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol Rev 75:725-748
4. Thompson PE, Manganiello V, Degerman E 2007 Re-discovering PDE3 inhibitors-new opportunities for a long neglected target. Curr Top Med Chem 7:421-436
5. Pauvert O, Salvail D, Rousseau E, Lugnier C, Marthan R, Savineau JP 2002 Characterisation of cyclic nucleotide phosphodiesterase isoforms in the media layer of the main pulmonary artery. Biochem Pharmacol 63:1763-1772
6. Thelitz S, Oishi P, Sanchez LS, Bekker JM, Ovadia B, Johengen MJ, Black SM, Fineman JR 2004 Phosphodiesterase-3 inhibition prevents the increase in pulmonary vascular resistance following inhaled nitric oxide withdrawal in lambs. Pediatr Crit Care Med 5:234-239
7. Walsh-Sukys MC, Tyson JE, Wright LL, Bauer CR, Korones SB, Stevenson DK, Verter J, Stoll BJ, Lemons JA, Papile L, Shankaran S, Donovan EF, Oh W, Ehrenkranz RA, Fanaroff AA 2000 Persistent pulmonary hypertension of the newborn in the era before nitric oxide: practice variation and outcomes. Pediatrics 105:14-20
8. 1997 Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. The Neonatal Inhaled Nitric Oxide Study Group. N Engl J Med 336:597-604
9. Roberts JD, Fineman JR, Morin FC III, Shaul PW, Rimar S, Schreiber MD, Polin RA, Zwass MS, Zayek MM, Gross I, Heymann MA, Zapol WM, Thusu KG, Zellers TM, Wylam ME, Zaslavsky A 1997 Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. N Engl J Med 336:605-610
10. Deb B, Bradford K, Pearl R 2000 Additive effects of inhaled nitric oxide and intravenous milrinone in experimental pulmonary hypertension. Crit Care Med 28:795-799 (Pubitemid 30174280)
11. Bassler D, Choong K, McNamara P, Kirpalani H 2006 Neonatal persistent pulmonary hypertension treated with milrinone: four case reports. Biol Neonate 89:1-5
12. McNamara PJ, Laique F, Muang-In S, Whyte HE 2006 Milrinone improves oxy-genation in neonates with severe persistent pulmonary hypertension of the newborn. J Crit Care 21:217-222
13. Maclean MR, Johnston ED, McCulloch KM, Pooley L, Houslay MD, Sweeney G 1997 Phosphodiesterase isoforms in the pulmonary arterial circulation of the rat: changes in pulmonary hypertension. J Pharmacol Exp Ther 283:619-624
14. Murray F, MacLean MR, Pyne NJ 2002 Increased expression of the cGMP-inhibited cAMP-specific (PDE3) and cGMP binding cGMP-specific (PDE5) phosphodiester-ases in models of pulmonary hypertension. Br J Pharmacol 137:1187-1194
15. Lakshminrusimha S, Russell JA, Steinhorn RH, Swartz DD, Ryan RM, Gugino SF, Wynn KA, Kumar VH, Mathew B, Kirmani K, Morin FC III 2007 Pulmonary hemodynamics in neonatal lambs resuscitated with 21%, 50%, and 100% oxygen. Pediatr Res 62:313-318
16. Lakshminrusimha S, Russell J, Wedgwood S, Gugino S, Kazzaz J, Davis J, Steinhorn R 2006 Superoxide dismutase improves oxygenation and reduces oxidation in neonatal pulmonary hypertension. Am J Respir Crit Care Med 174:1370-1377
17. Smith ID 1967 Breed differences in the duration of gestation in sheep. Aust Vet J 43:63-64
18. Farrow KN, Groh BS, Schumacker PT, Lakshminrusimha S, Czech L, Gugino SF, Russell JA, Steinhorn RH 2008 Hyperoxia increases phosphodiesterase 5 expression and activity in ovine fetal pulmonary artery smooth muscle cells. Circ Res 102:226-233
19. Bradford MM 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
20. Steinhorn RH, Morin FC III, Gugino SF, Giese EC, Russell JA 1993 Developmental differences in endothelium-dependent responses in isolated ovine pulmonary arteries and veins. Am J Physiol 264:H2162-H2167
21. Gao Y, Tolsa JF, Shen H, Raj JU 1998 Effect of selective phosphodiesterase inhibitors on response of ovine pulmonary arteries to prostaglandin E2. J Appl Physiol 84:13-18
22. Hentschel T, Yin N, Riad A, Habbazettl H, Weimann J, Koster A, Tschope C, Kuppe H, Kuebler W 2007 Inhalation of the phosphodiesterase-3 inhibitor milrinone attenuates pulmonary hypertension in a rat model of congestive heart failure. Anesthesiology 106:124-131
23. Fineman JR, Soifer SJ, Heymann MA 1995 Regulation of pulmonary vascular tone in the perinatal period. Annu Rev Physiol 57:115-134
24. Shaul PW, Farrar MA, Magness RR 1993 Pulmonary endothelial nitric oxide production is developmentally regulated in the fetus and newborn. Am J Physiol 265:H1056-H1063
25. Liu H, Maurice DH 1998 Expression of cyclic GMP-inhibited phosphodiesterases 3A and 3B (PDE3A and PDE3B) in rat tissues: differential subcellular localization and regulated expression by cyclic AMP. Br J Pharmacol 125:1501-1510
26. Black SM, Heidersbach RS, McMullan DM, Bekker JM, Johengen MJ, Fineman JR 1999 Inhaled nitric oxide inhibits NOS activity in lambs: potential mechanism for rebound pulmonary hypertension. Am J Physiol 277:H1849-H1856
27. Lakshminrusimha S, Porta NF, Farrow KN, Chen B, Gugino SF, Kumar VH, Russell JA, Steinhorn RH 2009 Milrinone enhances relaxation to prostacyclin and iloprost in pulmonary arteries isolated from lambs with persistent pulmonary hypertension of the newborn. Pediatr Crit Care Med 10:106-112